Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hebert

Showing results (451-460 of 460) with videos related to

Pageof 46
Sort By:
You have reached the last page of results.This site can display upto 460 results.
Pediatric Dermatology|March 31, 2018
Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industryElaine C Siegfried, Jennifer C Jaworski, Lawrence F Eichenfield, et al.
Journal of the American Academy of Dermatology|November 4, 2004
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acneJohn J DiGiovanna, Craig B Langman, Eduardo H Tschen, et al.
Pediatric Dermatology|June 14, 2023
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelinesElaine C Siegfried, Lisa M Arkin, Yvonne E Chiu, et al.
The New England Journal of Medicine|September 8, 2010
Intensive blood-pressure control in hypertensive chronic kidney diseaseLawrence J Appel, Jackson T Wright, Tom Greene, et al.
Nephron|June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1Barry I Freedman, Carl D Langefeld, Kelly K Andringa, et al.
The British Journal of Dermatology|July 2, 2014
Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)J R Chalmers, J Schmitt, C Apfelbacher, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Archives of Dermatological Research|December 1, 2022
The Association of Academic Cosmetic Dermatology: improving cosmetic dermatology education through collaboration, research, and advocacyKira Minkis, Diana Bolotin, M Laurin Council, et al.
Archives of Dermatological Research|December 3, 2022
Needs and Gaps in Resident Trainee Education, Clinical Patient Care, and Clinical Research in Cosmetic Dermatology: Position Statement of the Association of Academic Cosmetic DermatologyKira Minkis, Diana Bolotin, M Laurin Council, et al.
Pageof 46

Showing results (451-460 of 460) with videos related to

Sort By:
Pageof 46
You have reached the last page of results.This site can display upto 460 results.
Pediatric Dermatology|March 31, 2018
Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industryElaine C Siegfried, Jennifer C Jaworski, Lawrence F Eichenfield, et al.
Journal of the American Academy of Dermatology|November 4, 2004
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acneJohn J DiGiovanna, Craig B Langman, Eduardo H Tschen, et al.
Pediatric Dermatology|June 14, 2023
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelinesElaine C Siegfried, Lisa M Arkin, Yvonne E Chiu, et al.
The New England Journal of Medicine|September 8, 2010
Intensive blood-pressure control in hypertensive chronic kidney diseaseLawrence J Appel, Jackson T Wright, Tom Greene, et al.
Nephron|June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1Barry I Freedman, Carl D Langefeld, Kelly K Andringa, et al.
The British Journal of Dermatology|July 2, 2014
Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)J R Chalmers, J Schmitt, C Apfelbacher, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Archives of Dermatological Research|December 1, 2022
The Association of Academic Cosmetic Dermatology: improving cosmetic dermatology education through collaboration, research, and advocacyKira Minkis, Diana Bolotin, M Laurin Council, et al.
Archives of Dermatological Research|December 3, 2022
Needs and Gaps in Resident Trainee Education, Clinical Patient Care, and Clinical Research in Cosmetic Dermatology: Position Statement of the Association of Academic Cosmetic DermatologyKira Minkis, Diana Bolotin, M Laurin Council, et al.
Pageof 46